1. Home
  2. BDSX vs IXHL Comparison

BDSX vs IXHL Comparison

Compare BDSX & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • IXHL
  • Stock Information
  • Founded
  • BDSX 2005
  • IXHL 2001
  • Country
  • BDSX United States
  • IXHL Australia
  • Employees
  • BDSX N/A
  • IXHL N/A
  • Industry
  • BDSX Precision Instruments
  • IXHL
  • Sector
  • BDSX Health Care
  • IXHL
  • Exchange
  • BDSX Nasdaq
  • IXHL Nasdaq
  • Market Cap
  • BDSX 53.0M
  • IXHL 49.1M
  • IPO Year
  • BDSX 2020
  • IXHL N/A
  • Fundamental
  • Price
  • BDSX $7.19
  • IXHL $0.34
  • Analyst Decision
  • BDSX Strong Buy
  • IXHL
  • Analyst Count
  • BDSX 5
  • IXHL 0
  • Target Price
  • BDSX $32.50
  • IXHL N/A
  • AVG Volume (30 Days)
  • BDSX 322.6K
  • IXHL 21.2M
  • Earning Date
  • BDSX 11-03-2025
  • IXHL 11-14-2025
  • Dividend Yield
  • BDSX N/A
  • IXHL N/A
  • EPS Growth
  • BDSX N/A
  • IXHL N/A
  • EPS
  • BDSX N/A
  • IXHL N/A
  • Revenue
  • BDSX $80,173,000.00
  • IXHL $12,000.00
  • Revenue This Year
  • BDSX $19.04
  • IXHL $1,188.37
  • Revenue Next Year
  • BDSX $26.39
  • IXHL N/A
  • P/E Ratio
  • BDSX N/A
  • IXHL N/A
  • Revenue Growth
  • BDSX 22.29
  • IXHL N/A
  • 52 Week Low
  • BDSX $3.44
  • IXHL $0.08
  • 52 Week High
  • BDSX $32.20
  • IXHL $2.25
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 49.20
  • IXHL 42.83
  • Support Level
  • BDSX $7.42
  • IXHL $0.35
  • Resistance Level
  • BDSX $8.52
  • IXHL $0.38
  • Average True Range (ATR)
  • BDSX 0.85
  • IXHL 0.03
  • MACD
  • BDSX -0.05
  • IXHL 0.00
  • Stochastic Oscillator
  • BDSX 37.11
  • IXHL 12.44

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: